Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Valuck

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Neuropsychiatric Disease and Treatment|July 18, 2012
Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart reviewDaniel A Hoffman, Charles Debattista, Robert J Valuck, et al.
Pharmacoepidemiology and Drug Safety|October 31, 2006
Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to presentDavid L McClure, Robert J Valuck, Morton Glanz, et al.
Pediatric Neurology|July 9, 2010
Intravenous levetiracetam in the management of acute seizures in childrenPamela D Reiter, Ashley D Huff, Kelly G Knupp, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 15, 2015
Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future ResearchAngela S Czaja, Pamela D Reiter, M Lynn Schultz, et al.
Pediatrics|May 31, 2017
Beyond the Label: Steering the Focus Toward Safe and Effective PrescribingAngela S Czaja, Alexander G Fiks, Richard C Wasserman, et al.
Journal of the American Medical Directors Association|June 17, 2003
Contemporary issues in the diagnosis and treatment of late-life depressionSteven P Roose, Ira R Katz, Bruce G Pollock, et al.
The Journal of Clinical Psychiatry|February 7, 2008
Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims dataElaine H Morrato, John W Newcomer, Richard R Allen, et al.
Advances in Skin & Wound Care|May 20, 2014
A framework of quality improvement interventions to implement evidence-based practices for pressure ulcer preventionWilliam V Padula, Manish K Mishra, Mary Beth F Makic, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 2, 2015
Factors Influencing Adoption of Hospital-Acquired Pressure Ulcer Prevention Programs in US Academic Medical CentersWilliam V Padula, Robert J Valuck, Mary Beth F Makic, et al.
Journal of the American Geriatrics Society|July 2, 2011
Comparing antidepressant treatment patterns in older and younger adults: a claims database analysisThibaut Sanglier, Delphine Saragoussi, Dominique Milea, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Neuropsychiatric Disease and Treatment|July 18, 2012
Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart reviewDaniel A Hoffman, Charles Debattista, Robert J Valuck, et al.
Pharmacoepidemiology and Drug Safety|October 31, 2006
Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to presentDavid L McClure, Robert J Valuck, Morton Glanz, et al.
Pediatric Neurology|July 9, 2010
Intravenous levetiracetam in the management of acute seizures in childrenPamela D Reiter, Ashley D Huff, Kelly G Knupp, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 15, 2015
Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future ResearchAngela S Czaja, Pamela D Reiter, M Lynn Schultz, et al.
Pediatrics|May 31, 2017
Beyond the Label: Steering the Focus Toward Safe and Effective PrescribingAngela S Czaja, Alexander G Fiks, Richard C Wasserman, et al.
Journal of the American Medical Directors Association|June 17, 2003
Contemporary issues in the diagnosis and treatment of late-life depressionSteven P Roose, Ira R Katz, Bruce G Pollock, et al.
The Journal of Clinical Psychiatry|February 7, 2008
Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims dataElaine H Morrato, John W Newcomer, Richard R Allen, et al.
Advances in Skin & Wound Care|May 20, 2014
A framework of quality improvement interventions to implement evidence-based practices for pressure ulcer preventionWilliam V Padula, Manish K Mishra, Mary Beth F Makic, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 2, 2015
Factors Influencing Adoption of Hospital-Acquired Pressure Ulcer Prevention Programs in US Academic Medical CentersWilliam V Padula, Robert J Valuck, Mary Beth F Makic, et al.
Journal of the American Geriatrics Society|July 2, 2011
Comparing antidepressant treatment patterns in older and younger adults: a claims database analysisThibaut Sanglier, Delphine Saragoussi, Dominique Milea, et al.
Pageof 7